Cite
MLA Citation
Annick Desjardins et al.. “CTIM-23. DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS).” Neuro-oncology, vol. 24, n.d., p. vii65. http://access.bl.uk/ark:/81055/vdc_100169741308.0x00001d